(EMAILWIRE.COM, November 25, 2009 ) Dallas, TX - Illumina, Inc. (NASDAQ:ILMN) climbed 5.62% to $27.99. The stock hit an intraday high and an intraday low of $28.15 and $26.20 respectively. In the last six months the stock went down over 21%. Illumina, Inc. is a developer, manufacturer and marketer of integrated systems for the large-scale analysis of genetic variation and biological function.

Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) climbed 6.17% to $13.24 after Barclays Capital said it sees several catalysts warranting an upgrade of Amylin Pharmaceuticals Inc. to overweight from equalweight, including recent progress with diabetes drug Byetta and obesity products. The firm also sees a $2.5 billion opportunity from exenatide LAR from patients previously initiating Byetta and believes regulatory risk may be less than reflected in the current share price.

Protalix BioTherapeutics Inc. (AMEX:PLX) climbed 9.72% to $10.72. The stock hit an intraday high and an intraday low of $10.72 and $9.69 respectively. In the last six months the stock went up over 192%. Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system.

ABOUT PennyStockPickAlert.com

Penny Stock Pick Alerts by PennyStockPickAlert.com. If you are planning to invest into Stock Market then you must subscribe to Free Stock Newsletter and Alerts. We are a leading stock web site that provides free stock alerts on hot penny stocks that are poised to make big gains. We also tracks small cap penny stocks that could be on the brink of a massive breakout

Contact Information:
PennyStockPickAlert.com
Robert Wilson
Tel: 214 556 6798
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.